Michael Baehr

827 total citations
31 papers, 597 citations indexed

About

Michael Baehr is a scholar working on Geriatrics and Gerontology, Pharmacology and Epidemiology. According to data from OpenAlex, Michael Baehr has authored 31 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Michael Baehr's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Medication Adherence and Compliance (5 papers). Michael Baehr is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Medication Adherence and Compliance (5 papers). Michael Baehr collaborates with scholars based in Germany, Australia and United Kingdom. Michael Baehr's co-authors include Claudia Langebrake, R. Stracke, Peer Briken, Klaus Wiedemann, Rüdiger Holzbach, Falk Kiefer, Holger Jahn, Dieter Naber, Dorothee C. Dartsch and Stefan Kluge and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Pharmaceutics.

In The Last Decade

Michael Baehr

28 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Baehr Germany 11 224 135 132 116 96 31 597
Amélie Daveluy France 14 89 0.4× 47 0.3× 53 0.4× 132 1.1× 34 0.4× 78 602
Miia Tiihonen Finland 15 42 0.2× 136 1.0× 28 0.2× 24 0.2× 56 0.6× 67 664
Albrecht Eisert Germany 17 44 0.2× 141 1.0× 82 0.6× 31 0.3× 10 0.1× 53 609
Christopher M. Herndon United States 15 30 0.1× 96 0.7× 16 0.1× 146 1.3× 23 0.2× 46 875
Kevin E. Anger United States 15 114 0.5× 20 0.1× 25 0.2× 38 0.3× 83 0.9× 37 874
Suying Yan China 10 26 0.1× 66 0.5× 28 0.2× 93 0.8× 58 0.6× 29 527
Joshua W. Elder United States 9 51 0.2× 33 0.2× 17 0.1× 93 0.8× 61 0.6× 21 351
Kęstutis Petrikonis Lithuania 11 75 0.3× 30 0.2× 26 0.2× 48 0.4× 108 1.1× 32 402
Chouki Chenaf France 14 77 0.3× 20 0.1× 29 0.2× 118 1.0× 24 0.3× 45 529
Jody M. Cleveland United States 10 228 1.0× 36 0.3× 51 0.4× 120 1.0× 5 0.1× 17 748

Countries citing papers authored by Michael Baehr

Since Specialization
Citations

This map shows the geographic impact of Michael Baehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baehr more than expected).

Fields of papers citing papers by Michael Baehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Baehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baehr. The network helps show where Michael Baehr may publish in the future.

Co-authorship network of co-authors of Michael Baehr

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Baehr. A scholar is included among the top collaborators of Michael Baehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Baehr. Michael Baehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florey, M. E., Ulf Schulze‐Sturm, Marc Lütgehetmann, et al.. (2023). High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022. Infection. 51(5). 1569–1575. 1 indexed citations
2.
Baehr, Michael, et al.. (2023). Life cycle assessment of pharmaceutical and clinical packaging required for medication administration practices. The International Journal of Life Cycle Assessment. 29(3). 416–432.
3.
4.
Wichmann, Dominic, et al.. (2023). Clinical pharmacy services in critical care: results of an observational study comparing ward-based with remote pharmacy services. International Journal of Clinical Pharmacy. 45(4). 847–856. 5 indexed citations
5.
Baehr, Michael, et al.. (2023). Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital. International Journal of Pharmaceutics. 643. 123218–123218. 17 indexed citations
6.
7.
Baehr, Michael, et al.. (2021). Die pharmakologische/pharmazeutische Visite in der Intensivmedizin. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 116(2). 173–184.
8.
Baehr, Michael, et al.. (2020). Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing. Frontiers in Pharmacology. 11. 172–172. 33 indexed citations
9.
Braune, Stephan, Christina König, Jason A. Roberts, et al.. (2018). Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study. Critical Care. 22(1). 25–25. 26 indexed citations
10.
König, Christina, Stephan Braune, Jason A. Roberts, et al.. (2017). Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis. Journal of Antimicrobial Chemotherapy. 72(5). 1433–1440. 19 indexed citations
11.
Katchanov, Juri, Benno Kreuels, Florian P. Maurer, et al.. (2017). Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study. BMC Infectious Diseases. 17(1). 131–131. 4 indexed citations
12.
Sommer, Claudia, et al.. (2016). Potentially Inappropriate Medication Use in Multimorbid Elderly Inpatients: Differences Between the FORTA, PRISCUS and STOPP Ratings. Drugs - Real World Outcomes. 3(3). 317–325. 36 indexed citations
13.
Baehr, Michael, et al.. (2014). Kopplung von elektronischer Verordnung und patientenorientierter Logistik. 35(4). 110–117. 3 indexed citations
14.
Baehr, Michael, et al.. (2014). PS-004 Efficacy of a closed loop medicines administration process to reduce the probability of medicines errors. European Journal of Hospital Pharmacy. 21(Suppl 1). A145.1–A145. 1 indexed citations
15.
Kriston, Levente, et al.. (2013). Reducing Cardiovascular Medication Complexity in a German University Hospital: Effects of a Structured Pharmaceutical Management Intervention on Adherence. Journal of Managed Care Pharmacy. 19(5). 396–407. 39 indexed citations
16.
Langebrake, Claudia, et al.. (2011). Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation. International Journal of Clinical Pharmacy. 33(6). 918–924. 6 indexed citations
17.
Kriston, Levente, et al.. (2011). Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI‐D). Journal of Evaluation in Clinical Practice. 18(3). 515–522. 32 indexed citations
18.
19.
Braune, Stephan, G. Kreymann, Michael Baehr, et al.. (2011). Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward?. Intensive Care Medicine. 37(8). 1311–1316. 26 indexed citations
20.
Kiefer, Falk, Holger Jahn, Peer Briken, et al.. (2003). Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism. Archives of General Psychiatry. 60(1). 92–92. 287 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amélie Daveluy Breakdown of academic impact, for papers by Miia Tiihonen Breakdown of academic impact, for papers by Albrecht Eisert Breakdown of academic impact, for papers by Christopher M. Herndon Breakdown of academic impact, for papers by Kevin E. Anger Breakdown of academic impact, for papers by Suying Yan Breakdown of academic impact, for papers by Joshua W. Elder Breakdown of academic impact, for papers by Kęstutis Petrikonis Breakdown of academic impact, for papers by Chouki Chenaf Breakdown of academic impact, for papers by Jody M. Cleveland
Rankless by CCL
2026